Omaygenç, Mehmet OnurKaraca, İbrahim OğuzGüler, EkremKızılırmak, FilizÇakal, BeytullahGüneş, Hacı MuratKılıçaslan, Fethi10.07.20192019-07-1010.07.20192019-07-102015Omaygenç, M. O., Karaca, İ. O., Güler, E., Kızılırmak, F., Çakal, B., Güneş, H. M. ve Kılıçaslan, F. (2015). Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure. Heart Rhythm, 12(5), 1057-1061. https://dx.doi.org/10.1016/j.hrthm.2015.01.0371547-52711556-3871https://dx.doi.org/10.1016/j.hrthm.2015.01.037https://hdl.handle.net/20.500.12511/2608WOS: 000353333100030PubMed ID: 25637564Treatment of supraventricular tachycardia (SVT) during pregnancy can be troublesome. Antiarrhythmic drugs (especially beta-blockers and calcium channel blockers) are frequently used for treatment of symptomatic patients. However, routine and long-term use of these drugs is not recommended because most of them are classified as categories C and D by the US Food and Drug Administration.eninfo:eu-repo/semantics/embargoedAccessPregnancyRadiofrequency Catheter AblationElectroanatomic Mapping SystemRadiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposureArticle1251057106110.1016/j.hrthm.2015.01.037Q1Q1